Gene immunotherapy in murine acute myeloid leukemia: Granulocyte- macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines

Blood

Volumn 91, Issue 1, 1998, Pages 222-230

  Dunussi Joannopoulos, Kyriaki ^a,b   Dranoff, Glenn ^a   Weinstein, Howard J ^a   Ferrara, James L M ^a   Bierer, Barbara E ^a   Croop, James M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN PRESENTING CELL; ARTICLE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR GROWTH; VACCINATION;

EID: 0031965021     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.1.222     Document Type: Article

References (61)

1. Russel NH: Biology of acute leukemia. Lancet 349:118, 1997
2. Zeleznik-Le NJ, Nicifora G, Rowley JD: The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities. Semin Hematol 32:201, 1995
3. Sawyers CL: Molecular genetics of acute leukemia. Lancet 349:196, 1997
4. Burnett AK, Eden OB: The treatment of acute leukemia. Lancet 349:270, 1997
5. Del Poeta G, Stasi R, Aronica G, Venditti A, Cox MC, Bruno A, Buccisano F, Masi M, Tribalto M, Amadori S, Papa G: Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood 87:1997, 1996
6. Bosch I, Croop JM: P-glycoprotein multidrug resistance and cancer. Biochem Biophys Acta 1288:37, 1996
7. Caron PC, Scheinberg DA: Immunotherapy for acute leukemias. Curr Opin Oncol 6:14, 1994
8. Schiffer CA: Hematopoietic growth factors as adjuncts to the treatment of acute myeloid leukemia. Blood 88:3675, 1996
9. Boon T, Cerottini JC, Van den Eynde B, Van der Bruggen P, Van Pel A: Tumor-antigens recognized by T lymphocytes. Annu Rev Immunol 12:337, 1994
10. Dranoff G, Mulligan RC: Gene transfer as cancer therapy. Adv Immunol 58:417, 1995
11. Chen L, Linsley PS, Hellström KE: Costimulation of T cells for tumor immunity. Immunol Today 14:483, 1993
12. Pardoll DM: Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol 13:399, 1995
13. Chen L, Ashe S, Brady WA, Hellström I, Hellström KE, Ledbetter JA, McGowan P, Linsley P: Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093, 1992
14. Townsend SE, Allison JP: Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259:368, 1993
15. Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E: Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172:1217, 1990
16. Tepper RI, Pattengale PK, Leder P: Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57:503, 1989
17. Sun WH, Kreisle RA, Philips AW, Ershler WB: In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. Cancer Res 52:5412, 1992
18. Watanabe Y, Kuribayashi K, Miyatake S, Nishikhara K, Nakayama E, Taniyama T, Sakata T: Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA 86:9456, 1989
19. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan R: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539, 1993
20. Colombo MP, Forni G: Cytokine gene transfer in tumor inhibition and tumor therapy: Where are we now? Immunol Today 15:48, 1994
21. Musiani P, Modesti A, Giovarelli M, Cavallo F, Colombo MP, Lollini PL, Forni G: Cytokines, tumour-cell death and immunogenicity: A question of choice. Immunol Today 18:32, 1997
22. Abe J, Wakimoto H, Aoyagi M, Hirakawa K, Hamada H: Cytokine-gene-modified tumor vaccination intensified by a streptococcal preparation OK-432. Cancer Immunol Immunother 41:82, 1995
23. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991
24. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693, 1992
25. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992
26. Matulonis UA, Dosiou C, Lamont C, Freeman GJ, Mauch P, Nadler LM, Griffin JD: Role of B7-1 in mediating an immune response to myeloid leukemia cells. Blood 85:2507, 1995
27. Dunussi-Joannopoulos K, Weinstein HJ, Nickerson PW, Strom TB, Burakoff SJ, Croop JM, Arceci RJ: Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood 87:2938, 1996
28. Matulonis U, Dosiou C, Freeman G, Lamont C, Mauch P, Nadler LM, Griffin JD: B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated anti-leukemia immunity. J Immunol 156:1126, 1996
29. Boyer MW, Vallera DA, Taylor PA, Gray GS, Katsanis E, Gorden K, Orchard PJ, Blazar BR: The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia properties. Blood 89:3477, 1997
30. Dunussi-Joannopoulos K, Krenger W, Weinstein HJ, Ferrara JLM, Croop JM: CD8+ T cells activated during the course of murine AML elicit therapeutic responses to late B7 vaccines after cytoreductive treatment. Blood 89:2915, 1997
31. Hodge JW, Abrams S, Schlom J, Kantor JA: Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res 54:5552, 1994
32. Martin-Fontecha A, Cavallo F, Bellone M, Heltai S, Iezzi G, Tornaghi P, Nabavi N, Forni G, Dellabona P, Casorati G: Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors. Eur J Immunol 26:1851, 1996
33. Gajewski TF: B7-1 but not B7-2 efficiently costimultes CD8+ T lymphocytes in the P815 tumor system in vitro. J Immunol 156:465, 1996
34. Resnitzky P, Estfov Z, Haran-Ghera N: High incidence of acute myeloid leukemia in SJL/J mice after x-irradiation and corticosteroids. Leuk Res 9:1519, 1985
35. Arceci RJ, Stieglitz K, Bras J, Schinkel A, Baas F, Croop J: A monoclonal antibody to an external epitope of the human mdr1-p-glycoprotein. Cancer Res 53:310, 1993
36. Wakimoto H, Abe J, Tsunoda R, Aoyagi M, Hirakawa K, Hamada H: Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4. Cancer Res 56:1828, 1996
37. Levitsky HI, Montgomery J, Ahmadzadeh M, Staveley-O'Carroll K, Guarnieri F, Longo DL, Kwak LW: Immunization with GM-CSF-transduced, but not B7-1-transduced lymphoma cells primes idiotype-specific T cells and generates potent anti-tumor immunity, J Immunol 156:3858, 1996
38. Vieweg J, Rosenthal FM, Bannerji R, Heston WDW, Fair WR, Gansbacher B, Gilboa E: Immunotherapy of prostate cancer in the Dunning rat model: Use of cytokine gene modified tumor vaccines. Cancer Res 54:1760, 1994
39. Pericle F, Giovarelli M, Colombo MP, Ferrari G, Musiani P, Modesti A, Cavallo F, Di Pierro F, Novelli F, Forni G: An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenosarcoma engineered to release IL-4. J Immunol 153:5659, 1994
40. Budel LM, Elbaz O, Hoogerbrugge H, Delwel R, Mahmoud RA, Löwenberg B, Touw IP: Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloidleukemia cells and monocytes. Blood 75:1439, 1990
41. Nicola NA: Receptors for colony-stimulating factors. Br J Haematol 77:133, 1991
42. Sperling AI, Auger JA, Ehst BD, Rulifson IC, Thompson CB, Bluestone JA: CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J Immunol 157:3909, 1996
43. Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM: The role of B7-1/B7-2:CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol Rev 153:5, 1996
44. Sperling A, Bluestone JA: The complexities of T-cell costimulation: CD28 and beyond. Immunol Rev 153:155, 1996
45. Van Gool SW, Vandenberghe P, De Boer M, Ceuppens JL: CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol Rev 153:47, 1996
46. Reinhold MI, Lindberg FP, Kersh GJ, Allen PM, Brown EJ: Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J Exp Med 185:1, 1997
47. Marengere LEM, Waterhouse HW, Duncan GS, Mittrucker HW, Feng GS, Mak TW: Regulation of T cell receptor signalling by tyrosine phosphatase SYP association with CTLA-4. Science 272:1170, 1996
48. Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, Barber M, Restivo VAJ, Ke X-Y, Gray GS, Nadler LM: CTLA-4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 92:811, 1995
49. Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, Fournier S, Cassel D, Brunner M, Allison JP: The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev 153:27, 1996
50. Linsley PS, Greene IL, Brady W, Bajorath J, Ledbetter JA, Peach R: Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793, 1994
51. Morton PA, Fu XT, Stewart JA, Giacoletto KS, White SL, Leysath CE, Evans RJ, Shieh JJ, Karr RW: Differential effects of CTLA-4 substitutions on the binding of human CD80(B7-1) and CD86(B7-2). J Immunol 156:1047, 1996
52. Gajewski TF, Fallarino F, Uyttenhove C, Boon T: Tumor rejection requires a CTLA-4 ligand provided by the host or expressed on the tumor: Superiority of B7-1 over B7-2 for active tumor immunization. J Immunol 156:2909, 1996
53. Schweitzer AN, Borriello F, Wong RCK, Abbas AK, Sharpe AH: Role of costimulators in T cell differentiation. J Immunol 158:2713, 1997
54. Leach DR, Krummel MF, Allison JP: Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734, 1996
55. Cavallo F, Giovarelli M, Gulino A, Vacca A, Stoppacciaro A, Modesti A, Forni G: Role of neutrophils and CD4+ T lymphocytes in primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol 149: 3627, 1992
56. Vellenga E, Ostapovicz D, O'Rourke B, Griffin JD: Effects of recombinant IL-3, GM-CSF, and G-CSF on the proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia 1:584, 1987
57. Delwel R, Salem M, Dorssers L, Wagemaker G, Clark S, Löwenberg B: Growth regulation of human acute myeloid leukemia: Effects of five recombinant hematopoietic growth factors in a serum-free culture system. Blood 72:1944, 1988
58. Lowenberg B, Touw IP: Hematopoietic growth factors and their receptors in acute leukemia. Blood 81:281, 1993
59. Qin H, Chatterjee SK: Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF. Hum Gene Ther 7:1853, 1996
60. Armstrong CA, Botella R, Galloway TH, Murray N, Kramp JM, Song IS, Ansel JC: Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res 56:2191, 1996
61. Gunji Y, Tagawa M, Matsubara H, Takenaga K, Shimada H, Kondo F, Suzuki T, Nakajima K, Sugaya M, Asano T, Ochiai T, Isono K, Kageyama H, Nakamura Y, Sakiyama S: Antitumor effect of murine colon carcinoma cells retrovirally transduced with interleukin-4 and granulocyte macrophage-colony stimulating factor genes. Oncology 54:69, 1997